Stemming the obesity-diabetes epidemic: Lifestyle changes and therapeutics

Nature Clinical Practice Nephrology

Volumn 4, Issue 9, 2008, Pages 486-487

  Schrier, Robert W ^a,b   Bogaert, Yolanda E ^b  

^a Department of Medicine ^*

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AMPUTATION; BLINDNESS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIABETES MELLITUS; DIET; DISEASE ASSOCIATION; DRUG EFFICACY; EPIDEMIC; EXERCISE; HEALTH CARE COST; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY DISEASE; KIDNEY FAILURE; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SHORT SURVEY; UNITED STATES;

ASPIRIN; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIFE STYLE; METABOLIC SYNDROME X; OBESITY; RENIN-ANGIOTENSIN SYSTEM;

EID: 50249124760     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0898     Document Type: Short Survey

References (11)

1. Knowler WC et al. for the Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393-403
2. Lindstrom JP et al. (2006) Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention study. Lancet 368: 1673-1679
3. Schwarz PE et al. (2006) Diabetes prevention from physiology to implementation. Horm Metab Res 38: 460-464
4. Schrier RW et al. (2007) Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of ABCD trial. Nat Clin Pract Nephrol 3: 428-438
5. Alberti KG and Zimmet PZ (2008) Should we dump the metabolic syndrome? No. BMJ 336: 641
6. Gaede P et al. (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358: 580-591
7. [No authors listed] (1993) UK Prospective Diabetes Study (UKPDS). X. Urinary albumin excretion over 3 years in diet-treated type 2, (non-insulin-dependent) diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyceridaemia. Diabetologia 36: 1021-1029
8. Estacio RO et al. (2000) Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care 23 (Suppl 2): B54-B64
9. Schrier RW et al. (2002) Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int 61: 1086-1097
10. Eddy DM et al. (2005) Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann Intern Med 143: 251-264
11. Law MR et al. (2003) Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 326: 1427